CLOs on the Move

Gladden Longevity

www.gladdenlongevity.com

 
Gladden Longevity is a comprehensive concierge medical program dedicated to health optimization and performance, with a focus on age reversal. They offer wellness and fitness services, neurocognitive testing, body composition analysis, cardiovascular p...
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

CareOregon Advantage

CareOregon Advantage is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

White Horse Village

White Horse Village Inc. is a non-profit, full service, lifecare community for people 62 and over, White Horse Village attracts those who want to design their own retirement lifestyle. The on-site Healthcare Center assures that our residents are provided with any necessary healthcare — be it temporary or permanent, personal care or skilled nursing care.

Laurel Health System

Laurel Health System is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Laurel Health System is based in Wellsboro, PA. You can find more information on Laurel Health System at www.laurelhs.org

Clinica Medical Research

Clinica Medical Research is a Waltham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sernova

Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.